A detailed history of Legacy Trust transactions in Incyte Corp stock. As of the latest transaction made, Legacy Trust holds 36,899 shares of INCY stock, worth $2.24 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
36,899
Previous 29,116 26.73%
Holding current value
$2.24 Million
Previous $1.83 Billion 14.98%
% of portfolio
0.52%
Previous 0.48%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$56.55 - $66.59 $440,128 - $518,269
7,783 Added 26.73%
36,899 $2.1 Billion
Q4 2023

Jan 24, 2024

SELL
$52.16 - $64.19 $1.28 Million - $1.57 Million
-24,472 Reduced 45.67%
29,116 $1.83 Billion
Q3 2023

Oct 16, 2023

BUY
$57.77 - $65.93 $55,054 - $62,831
953 Added 1.81%
53,588 $3.1 Billion
Q2 2023

Aug 08, 2023

SELL
$60.95 - $75.51 $214,970 - $266,323
-3,527 Reduced 6.28%
52,635 $3.28 Billion
Q1 2023

Apr 19, 2023

SELL
$70.23 - $86.01 $15,450 - $18,922
-220 Reduced 0.39%
56,162 $4.06 Billion
Q4 2022

Apr 03, 2023

BUY
$67.18 - $84.11 $3.79 Million - $4.74 Million
56,382 New
56,382 $4.53 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Legacy Trust Portfolio

Follow Legacy Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Trust, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Trust with notifications on news.